Cleared Traditional

K102621 - SOLSTICE

K102621 is an FDA 510(k) clearance for SOLSTICE, manufactured by Kerr Corporation. The device is a Class 2 Dental device with product code EBZ cleared through the Traditional 510(k) pathway after a 137-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2011
Decision
137d
Days
Class 2
Risk

K102621 is an FDA 510(k) clearance for the SOLSTICE. Classified as Activator, Ultraviolet, For Polymerization (product code EBZ), Class II - Special Controls.

Submitted by Kerr Corporation (Orange, US). The FDA issued a Cleared decision on January 28, 2011 after a review of 137 days - within the typical 510(k) review window.

This device falls under the Dental FDA review panel, regulated under 21 CFR 872.6070 - the FDA dental device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Dental review framework, consistent with the majority of Class II 510(k) submissions.

View all Kerr Corporation devices

FDA 510(k) Submission Details - K102621

510(k) Number K102621 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 13, 2010
Decision Date January 28, 2011
Days to Decision 137 days
Submission Type Traditional
Review Panel Dental (DE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
10d slower than avg
Panel avg: 127d · This submission: 137d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

EBZ Device Classification - Class 2, Special Controls

Product Code EBZ Activator, Ultraviolet, For Polymerization
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 872.6070
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Dental devices follow this clearance model.

Regulatory Peers - EBZ Activator, Ultraviolet, For Polymerization

All 141
Devices cleared under the same product code (EBZ) and FDA review panel - the closest regulatory comparables to K102621.
D1 LED CURING LIGHT, SPEC 3, DENTRONIX LED 3000
K121093 · Dxm Co., Ltd. · Nov 2012
BLUEPHASE STYLE
K110756 · Ivoclar Vivadent, Inc. · Aug 2011
VALO CORDLESS
K110582 · Ultradent Products, Inc. · Apr 2011
BLUEPHASE 20I
K091020 · Ivoclar Vivadent, Inc. · Jun 2009
VALO, MODEL 5919
K083647 · Ultradent Products, Inc. · Jan 2009
MINI LED AUTOFOCUS
K072181 · Satelec · Sep 2007